EAGLE, Idaho, March 25, 2025 /PRNewswire/ — Calling all pet parents! Are you tired of juggling vet records, scrambling for vaccination dates, and playing hide-and-seek with your pet’s medical history? VIP Petcare is throwing you a treat with the launch of the brand-new, totally free, and utterly “paw-some” Pet Portal!
Say goodbye to pet-parenting stress and hello to streamlined, simplified pet care.
“We know pet parents have enough to worry about,” says John Pearson, President of PetIQ, LLC, Parent Company of VIP Petcare. “That’s why we created the Pet Portal – to make managing your pet’s health as convenient as possible!”
What’s Inside the Pet Portal?
Think of the Pet Parent Portal as your pet’s personal assistant, available 24/7 in the palm of your hand. It’s like having a superhero sidekick for pet care!
“At PetIQ, we are all about reimagining pet ownership, making it as convenient and accessible as possible,” John adds. “With this new platform, pet parents can spend less time stressing and more time creating happy memories with their furry friends.”
Ready to give your pets the VIP treatment? Sign up for the Pet Portal today and let the tail-wagging begin!
Visit https://mypetportal.vippetcare.com/ to get started!
About PetIQ, LLC:
PetIQ, LLC is dedicated to delivering a smarter way for pet parents to help their pets live their best lives through convenient access to affordable veterinary products and services. With a mission to make pet care accessible to all, PetIQ offers a wide range of solutions to help pets live their happiest and healthiest lives.
Contact:
SOURCE PetIQ, LLC
SHANGHAI, March 30, 2025 /PRNewswire/ -- As the clear aligner business enters the second quarter of 2025,…
Preliminary data from Cohort 4 of the ENSURE study supports a novel enrichment strategy to…
--Data presented at the American College of Cardiology Annual Scientific Session show that the reduction…
Discover the Oral Probiotic That’s Reshaping Dental Health—Backed by 75,000+ Users and Groundbreaking Science ProDentim…
Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2…
– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted…